Regulatory pathways for innovative medicinal products for Switzerland
Feature ArticlesAnja Bührer, MSc • David Berner, PhD • Shayesteh Fürst-Ladani, MBA, MSc, GFMD
Biologics/ biosimilars/ vaccinesEuropePharmaceuticalsFeature ArticlesAnja Bührer, MSc • David Berner, PhD • Shayesteh Fürst-Ladani, MBA, MSc, GFMDBiologics/ biosimilars/ vaccinesEuropePharmaceuticals